Northwestern University Feinberg School of Medicine

Bio

Stem Cell Transplantation for Pediatric diseases Minimal residual disease in leukemia Neuroblastoma and its treatment Stem Cell differentiation Tumor vaccines.

Academic Focus

I have been involved in Clinical research for Neuroblastoma and stem cell transplantation. I have also for the past 26 year have a laboratory that was focused on several projects such as:
1. Minimal Residual Disease in leukemia and neuroblastoma using WT1 gene as a marker.
2. Hematopoietic stem cell differentiation primarily on neural differentiation.
3. The use of RT-PCR to assess chimerism post transplant.
4. Stem cell processing and storage.
5. neuroblastoma tumor stem cell identificati...[Read full text]
I have been involved in Clinical research for Neuroblastoma and stem cell transplantation. I have also for the past 26 year have a laboratory that was focused on several projects such as:
1. Minimal Residual Disease in leukemia and neuroblastoma using WT1 gene as a marker.
2. Hematopoietic stem cell differentiation primarily on neural differentiation.
3. The use of RT-PCR to assess chimerism post transplant.
4. Stem cell processing and storage.
5. neuroblastoma tumor stem cell identification and its role in disease development.[Shorten text]

Clinical Focus

My clinical focus has been related to Hematopoietic Stem Cell transplantation both autologous and allogeneic. I have also developed and participate at the national level in the development of therapeutic protocols for neuroblastoma , leukemia and lymphoma at the former Pediatric Oncology group and the Children's Oncology Group.
Most recently I have been the Institutional PI for the Pediatric Immune Deficiency consortium developing protocols for the transplant of patients affected with immune def...[Read full text]
My clinical focus has been related to Hematopoietic Stem Cell transplantation both autologous and allogeneic. I have also developed and participate at the national level in the development of therapeutic protocols for neuroblastoma , leukemia and lymphoma at the former Pediatric Oncology group and the Children's Oncology Group.
Most recently I have been the Institutional PI for the Pediatric Immune Deficiency consortium developing protocols for the transplant of patients affected with immune deficiency disorders.[Shorten text]

 

Education and Certification

  • MD: Facultad de Medicina de la UNAM (1971)
  • Internship: University of Tel Aviv, Pediatrics (1972)
  • Residency: University of Arkansas Hospital, Pediatrics (1977)
  • Fellowship: University of Texas/MD Anderson Cancer Center, Hematology/Oncology (1980)
  • Board Certification: Pediatric Hematology-Oncology, Pediatrics